In addition, followingstability experiments and further work that showed that some of thedescribed leads directly bind MYC, and effectively enter the cells,we proceeded to in vivo pharmacokinetic studies in mice, which providedfurther evidence that efficacy in cancer models is possible. The gene discussed is MYC; the disease is cancer.